Silencing of APE1 enhances sensitivity of human hepatocellular carcinoma cells to radiotherapy in vitro and in a xenograft model.
about
Involvement of DNA damage response pathways in hepatocellular carcinoma.Identification of a novel potential antitumor activity of gossypol as an APE1/Ref-1 inhibitor.APE1/Ref-1 as an emerging therapeutic target for various human diseases: phytochemical modulation of its functionsFunctional analysis of tanshinone IIA that blocks the redox function of human apurinic/apyrimidinic endonuclease 1/redox factor-1.Apurinic/apyrimidinic endonuclease 1 induced upregulation of fibroblast growth factor 2 and its receptor 3 induces angiogenesis in human osteosarcoma cells.Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer.Transcriptional Up-Regulation of APE1/Ref-1 in Hepatic Tumor: Role in Hepatocytes Resistance to Oxidative Stress and Apoptosis.Pharmacogenetics Biomarkers and Their Specific Role in Neoadjuvant Chemoradiotherapy Treatments: An Exploratory Study on Rectal Cancer Patients.Human apurinic/apyrimidinic endonuclease 1.Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models.APE1 overexpression is associated with poor survival in patients with solid tumors: a meta-analysisResistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight.GADD45α sensitizes cervical cancer cells to radiotherapy via increasing cytoplasmic APE1 level.The regulatory role of APE1 in epithelial-to-mesenchymal transition and in determining EGFR-TKI responsiveness in non-small-cell lung cancer
P2860
Q33616812-D2F85304-5EB3-4DDA-97AA-734FAEBC9CFEQ33632423-2DA2D38D-E54A-44D2-8F4D-62BDFBA41636Q33990581-40F454DD-87BD-43EA-A9CB-E7186F4A35DEQ34470985-0395C329-13DB-4970-9341-329A887169E1Q35051513-2DE7DAB7-7E90-4198-83B2-11458D405132Q35743521-391C997E-9FB6-4488-AC63-79A45FC620E7Q35857124-DD7F2425-A0E2-4855-9ADC-62FB69B5ECDCQ37286470-639BAAD3-A6EF-4321-9D4E-0C5D0CEB5CB4Q37512952-803E9955-5B4F-4084-8325-4B0373253871Q38734017-8F033B92-EB88-4BD2-B7F1-558D01F206FAQ41708684-ACC92819-4AC1-4E64-86B9-403CA21C5235Q52345488-D9667598-8DFD-439E-8D80-B007A157E177Q55287375-777FAE41-490B-4CD7-A40E-6E0340443BC2Q58779784-DCDBC298-80DF-429F-B46C-B080DCB01139
P2860
Silencing of APE1 enhances sensitivity of human hepatocellular carcinoma cells to radiotherapy in vitro and in a xenograft model.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Silencing of APE1 enhances sen ...... itro and in a xenograft model.
@ast
Silencing of APE1 enhances sen ...... itro and in a xenograft model.
@en
Silencing of APE1 enhances sen ...... itro and in a xenograft model.
@nl
type
label
Silencing of APE1 enhances sen ...... itro and in a xenograft model.
@ast
Silencing of APE1 enhances sen ...... itro and in a xenograft model.
@en
Silencing of APE1 enhances sen ...... itro and in a xenograft model.
@nl
prefLabel
Silencing of APE1 enhances sen ...... itro and in a xenograft model.
@ast
Silencing of APE1 enhances sen ...... itro and in a xenograft model.
@en
Silencing of APE1 enhances sen ...... itro and in a xenograft model.
@nl
P2093
P2860
P1433
P1476
Silencing of APE1 enhances sen ...... itro and in a xenograft model.
@en
P2093
Chengjie Xiong
Chengyuan Qian
Jiangdong Sui
Mengxia Li
Yanping Cun
P2860
P304
P356
10.1371/JOURNAL.PONE.0055313
P407
P577
2013-02-13T00:00:00Z